ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026
Hip fracture risk in patients with Cushing's syndrome: a population-based cohort study.
Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cushing's syndrome causes bone loss, yet the risk of hip fractures remains poorly defined. In this nationwide cohort, patients showed a modestly increased risk of hip fracture, particularly soon after diagnosis. These results underscore the importance of early osteoporosis screening and timely fracture prevention strategies.
backgroundGlucocorticoid-induced osteoporosis is a common complication of Cushing's syndrome (CS). While the increased risk for vertebral fractures is well-established, evidence regarding hip fracture risk is limited. This study investigates the association between endogenous CS and hip fracture risk and examines the effect of remission on this risk.
methodsA nationwide retrospective matched-cohort study was conducted using the Clalit Health Services database in Israel, including patients diagnosed with endogenous CS between 2000 and 2023. Patients with CS were matched 1:5 to controls based on age, sex, socioeconomic status, and body mass index. The primary outcome was the first diagnosis of hip fractures following the diagnosis of CS. Patients with a history of hip fractures prior to CS diagnosis were excluded.
resultsThe study included 606 patients with CS and 2,988 matched controls, with a mean age at diagnosis of 47.8 ± 17.1 years; 65.3% were female. Follow-up durations were 14.0 ± 6.5 years for patients with CS and 14.5 ± 6.5 years for controls. Hip fractures occurred in 3.9% of patients with CS and 2.5% of matched controls, corresponding to a modest association in competing risk analysis (HR 1.57, 95% CI 1.0-2.5; p = 0.05). The risk was higher among patients with Cushing's disease (CD) (HR 2.2, 95% CI 1.07-4.75; p = 0.03) but not in those with an adrenal source (HR 1.3, 95% CI 0.6-2.8). Analysis by remission status showed that hip fractures occurred in 4.3% of patients without remission and 3.6% of those in remission, with no significant difference between groups (HR 1.14, 95% CI 0.4-3.0). In multivariate analysis, older age at CS diagnosis and pre-existing osteoporosis were independently associated with an increased risk of hip fracture.
conclusionEndogenous Cushing's syndrome may be associated with an increased hip fracture risk, particularly in CD, driven mainly by older age at diagnosis and pre-existing osteoporosis, with no significant risk reduction after remission. These findings underscore the need for early fracture risk assessment and targeted osteoporosis management in patients with CS.
Indexed as
Identifiers
42911249What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.